News

Base Shelf Prospectus Accessible and Prospectus Supplement to be Accessible on SEDAR+ VANCOUVER, British Columbia, July 14, 2025 (GLOBE NEWSWIRE) ...
Asston Pharmaceuticals' IPO allotment status has been finalized, allowing investors to verify their status through Maashitla ...
The sector has been hammered, but Oppenheimer rates both Blue Owl and KKR stock at Buy, and sees double-digit percentage upside.